Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1663 USD | +0.73% | +24.10% | -7.82% |
Business Summary
Number of employees: 9
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Care
71.0
%
| 9 | 71.3 % | 9 | 71.0 % | +4.62% |
Animal Care
18.8
%
| 3 | 25.1 % | 3 | 18.8 % | -21.11% |
Service/Royalty
10.1
%
| 0 | 3.6 % | 1 | 10.1 % | +199.78% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
30.5
%
| - | - | 4 | 30.5 % | - |
United States
25.8
%
| 4 | 30.1 % | 3 | 25.8 % | -9.96% |
Asia
18.5
%
| - | - | 2 | 18.5 % | - |
Latin America
18.0
%
| 2 | 16.6 % | 2 | 18.0 % | +13.75% |
Rest of the World
7.2
%
| - | - | 1 | 7.2 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 19-09-26 |
John Poggetto
DFI | Director of Finance/CFO | 53 | 01-12-31 |
Jerome Dvonch
DFI | Director of Finance/CFO | 56 | 20-09-07 |
Bruce Thornton
COO | Chief Operating Officer | 60 | 04-02-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 19-09-26 |
Jay Birnbaum
BRD | Director/Board Member | 79 | 07-04-19 |
Director/Board Member | 64 | 18-09-18 | |
John Mclaughlin
BRD | Director/Board Member | 76 | 13-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,607,433 | 15,364,446 ( 98.44 %) | 0 | 98.44 % |
Company contact information
Sonoma Pharmaceuticals, Inc.
5445 Conestoga Court Suite 150
80301, Boulder
+800 759 9305
http://www.sonomapharma.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.82% | 2.58M | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Sonoma Pharmaceuticals, Inc. - Nasdaq
- Company Sonoma Pharmaceuticals, Inc.